All In Biotech

Investigational drug · Phase 3

Human Diploid Cell

Also called: Inactivated Hepatitis A Vaccine, Healive, Experimental Lyophilized Human Rabies Vaccine

Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Hepatitis A Vaccine, Rabies Prevention.

Phase 3

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

2

2 still active

All registered trials

67

Any phase or sponsor naming "Human Diploid Cell"

First trial start

2026

Mar 4, 2026

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "Human Diploid Cell", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Hepatitis A Vaccine
  • Rabies Prevention

Approved drugs for the same conditions: Infectious disease and vaccines

Largest trials

Live from ClinicalTrials.gov: studies naming "Human Diploid Cell" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 783 on PubMed

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.